News
Welcome to the inaugural issue of the Food Exec Brief — our new weekly roundup of key headlines for food manufacturing ...
DOJ filed the statement of interest in United States District Court for the case Children’s Health Defense et al. v. Washington Post et al., which lists among its defendants the BBC, Reuters, the ...
The portrayal of uncaring scientists without any thought for the animals being used in their research is far from the truth.
Texas lawsuit over drugs and vaccines provided by insurers ends with a win for the government — and HHS Secretary Robert F.
US regulators approved Moderna Inc.’s COVID-19 vaccine for children, but for a narrower group than before, continuing Robert ...
The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.
ASX health stocks fall o.92% over past five days as US President Donald Trump renews threat to impose tariffs on pharmaceutical imports.
Health Secretary Robert F. Kennedy Jr. looks poised to win the battle over fluoride, to the dismay of dentists and oral ...
Secretary Kennedy’s latest maneuver seeks to expand vaccine injury lawsuits, echoing a precarious time in US history when ...
The partnership will focus first on "enabling research around the root causes" of autism spectrum disorder (ASD), HHS said. Researchers can use the platform to identify autism diagnosis trends ...
In this week’s edition of InnovationRx, we look at Immuneering’s slow-and-steady approach to cancer fighting, litigation over ...
H2 2025 catalysts to watch, biopharma implications of President Trump’s tax law, KalVista’s new hereditary angioedema drug that Marty Makary reportedly tried to reject, another lawsuit aimed at Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results